Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-07-11 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized during the quarter ended June 30, 2025. It is a confirmation letter from the Registrar and Transfer Agent (RTA) to the company secretary. The document does not contain financial statements or substantive financial data, nor is it a full report. It is primarily a regulatory compliance certificate confirming dematerialization activities for a quarter. The document length is 3422 characters, which is relatively short and consistent with a certification or confirmation letter. According to the rules, such officer certifications or confirmations, even if referencing a quarterly period, should be classified as Regulatory Filings (RNS).
2025-07-11 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated July 11, 2025, issued by Indegene Limited. It is addressed to shareholders and details the process for remote e-voting on a special resolution regarding the variation in utilization of IPO proceeds. The document references compliance with SEBI regulations, Companies Act provisions, and Ministry of Corporate Affairs circulars. It includes voting start and end dates, instructions for electronic voting, and a detailed explanation of the resolution to be voted on. The document is a notice to shareholders to seek their approval via postal ballot and remote e-voting, not the announcement of voting results or the report of the vote outcome. It is not a financial report, management discussion, or earnings release. It is also not a proxy solicitation or AGM material but specifically a Postal Ballot Notice. According to the filing definitions, this fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) if it were announcing results, but since it is the notice for voting, it is more aligned with Proxy Solicitation & Information Statement (PSI). However, the PSI category is for materials sent to shareholders to provide information and request votes for meetings, which matches a postal ballot notice. Therefore, the correct classification is PSI.
2025-07-11 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the Board of Directors' approval of a variation in the terms of utilization of IPO proceeds, subject to shareholder approval via postal ballot. It is an announcement of a corporate action related to capital use and shareholder voting, but it does not contain financial statements or detailed financial data. The document is short (1840 characters) and serves as an update on financing and capital use rather than a full report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP).
2025-07-10 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated July 3, 2025, announcing a strategic partnership between FAST India and Indegene to advance the Indian biotech ecosystem. It is addressed to stock exchanges and references compliance with SEBI regulations for disclosure. The content is promotional and informative about the collaboration, with no financial data, no report attached or referenced as being published, and no regulatory filing or certification. It is not an earnings release, annual report, or any financial or governance report. It is a straightforward press release announcing a corporate partnership and collaboration initiative. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and disclosures that do not fit other specific categories.
2025-07-03 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated June 30, 2025, announcing that Indegene has been identified as a leader in ISG's Provider Lens evaluation for Life Sciences Digital Services. It is addressed to stock exchanges pursuant to SEBI regulations and includes a summary of the recognition and company statements. There is no financial data, no detailed report, no voting results, no management changes, no earnings data, and no regulatory filings beyond the announcement itself. The document is short (4385 characters) and serves as a public relations announcement rather than a financial or regulatory report. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-06-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report of voting results from the 27th Annual General Meeting (AGM) of Indegene Limited held on June 26, 2025. It includes combined voting results from remote e-voting and e-voting during the AGM, pursuant to Regulation 44 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the Companies Act, 2013. The document also contains the Scrutinizer's Report, which is a formal report on the voting process and results. The content focuses exclusively on the voting outcomes of resolutions passed at the AGM, including adoption of financial statements, appointment of directors, declaration of dividends, and appointment of auditors. There is no indication that this document is the Annual Report itself or any other type of report. It is not a mere announcement of voting results but a comprehensive report including detailed vote counts and percentages, fulfilling the criteria for Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (over 14,000 characters) and detailed tabular data support this classification. Therefore, the appropriate filing type is DVA.
2025-06-27 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.